MacroGenics | MGNX - Trade Debtors


MacroGenics reported $13.37M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
AbbVie USD 12.77B 132M Sep/2025
Amgen USD 9.57B 1.08B Dec/2025
AstraZeneca USD 19.05B 1.49B Dec/2025
Biogen USD 1.85B 234M Sep/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Daiichi Sankyo JPY 695.95B 79.1B Dec/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Genmab DKK 1.17B 119M Dec/2025
Geron USD 37.66M 1.71M Sep/2025
Gilead Sciences USD 4.91B 182M Dec/2025
J&J USD 21.33B 3.72B Dec/2025
Karyopharm Therapeutics USD 26.18M 5.6M Dec/2025
MacroGenics USD 13.37M 55.86M Dec/2025
Merck USD 12.12B 596M Sep/2025
Pfizer USD 18.12B 2.02B Sep/2025
Puma Biotechnology USD 28.1M 3.52M Jun/2024
Regeneron Pharmaceuticals USD 5.74B 54M Dec/2025
Roche Holding CHF 11.9B 460M Dec/2025
Xencor USD 29.3M 7.49M Dec/2025